Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v4-EN
Language English English
Date Updated 2021-09-28 2021-09-27
Drug Identification Number 02470330 02470330
Brand name FOQUEST FOQUEST
Common or Proper name methylphenidate hydrochloride Controlled Release Capsules methylphenidate hydrochloride Controlled Release Capsules
Company Name ELVIUM LIFE SCIENCES ELVIUM LIFE SCIENCES
Ingredients METHYLPHENIDATE HYDROCHLORIDE METHYLPHENIDATE HYDROCHLORIDE
Strength(s) 70MG 70MG
Dosage form(s) CAPSULE (CONTROLLED RELEASE) CAPSULE (CONTROLLED RELEASE)
Route of administration ORAL ORAL ORAL ORAL
Packaging size 60 60
ATC code N06BA N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2021-09-17 2021-09-17
Actual start date 2021-09-17 2021-09-17
Estimated end date 2021-09-30 2021-09-30
Actual end date 2021-09-27 2021-09-27
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments